5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors Meeting Abstract
| Authors: | Sonpavde, G.; Manitz, J.; Gao, C.; Hennessy, D.; Makari, D.; Niegisch, G.; Rosenberg, J. E.; Bajorin, D. F.; Grivas, P.; Apolo, A. B.; Dreicer, R.; Hahn, N. M.; Galsky, M. D.; Necchi, A.; Srinivas, S.; Powles, T.; Gupta, A. K.; Abdullah, S. E.; Pond, G. R. |
| Abstract Title: | 5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 276s |
| Language: | English |
| ACCESSION: | WOS:000487345805375 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.4552 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4552 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
